East End - Long Island, New York

XBB COVID vaccine estimated effective rate: 63% to 68% against more severe illness in kids

Primary tabs

posted by mike kraft on Fri, 2024-12-13 11:41

XBB COVID vaccine estimated effective rate: 63% to 68% against more severe illness in kids

XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids The adjusted effectiveness of the updated Pfizer/BioNTech COVID-19 XBB vaccine in the 2023-24 US respiratory virus season was 68% and 63% against hospitalization or emergency department (ED) or urgent-care visits among children aged 5 to 11 years and 12 to 17 years, respectively, with an overall effectiveness for both age-groups of 65%, a Kaiser Permanente Southern California (KPSC)-led research team estimates. CIDRAP

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

- Private group -

Log in or register to post comments

Workflow history

Revision ID	Field name	Date	Old state	New state name	By	Comment	Operations
			No state	No state

Language

Anonymous's groups in this site

User is not a member of any group.

Your groups across all your sites

User is not a member of any group.

Recent Content

NIH director says Trump's anti-DEI orders misunderstood and agency still supports research that advances health of minorities.

Housing: 60,000 Americans to lose their rental assistance and risk eviction unless Congress renews funds

Trump administration cuts lab dealing with sexually transmitted diseases as syphillis cases rise.

NIH considering halting all new research grants to half a dozen top universities.

Proposed Medicaid cuts risk making the Black maternal health crises worse.

Who's online

There are currently 0 users online.